-
This is the second article of a two-part series on how to reduce the risk of infection for patients with indwelling bladder catheters.
-
Closing a home health agency branch office or an entire service line is more than just a business decision. The action affects a wide range of people with whom close relationships have developed over the years, so the timing and type of communication is important.
-
An overnight delivery of pain medication that took four days and a charge of $125 for eight pills from a hospital pharmacy are two of the reasons that the staff at Hospice of the Hills in Rapid City, SD, started looking for a new way to help patients with emergency needs.
-
Consumer direction of personal assistance services (CD-PAS) can offer Medicaid beneficiaries flexibility and independence to individualize their services. Analysts recognize that having greater control over these services is a high priority for some, but not all, disabled Medicaid beneficiaries.
-
It's a tough time to be a home health manager. For years, you've implemented new processes and new services designed to strengthen your agency, but it's hard to fight an economic environment that is forcing all industries to reevaluate how they conduct business.
-
Terumo Heart (Ann Arbor, Michigan) moved another step closer in its quest to release its DuraHeart Left Ventricular Assist System on the market, after the Institutional Review Board of the University of Michigan voted in late June to move forward with the device's pivotal trial for a bridge-to-transplant indication.
-
AGA Medical Holdings; Boston Scientific; Cambridge Heart; FlowCardia; MedCath; Quintiles Transnational; Signalife; Stereotaxis; Xtent
-
Despite the fact that it is the only FDA-approved drug to treat ischemic stroke, Activase, also known as tissue plasminogen activator (tPA), a product from Genentech (South San Francisco, California) is not used in the majority of cases for which it is approved.
-
SAN FRANCISCO Remote monitoring of implanted cardiac devices is hot at least at the level of discussion during scientific conferences, if not at the level of reimbursement of such services. But one step at a time: This technology clearly is adding more evidence concerning efficacy, if not clear cost-effectiveness.
-
BARCELONA, Spain EuroPCR, a prestigious meeting organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), an association of the European Society of Cardiology (Sophia Antipolis, France) and a group focused on interventional devices used for diagnosis and treatment of cardiovascular disease, is the leading interventional meeting in Europe and an important forum for introducing new devices.
